FDA backs Pfizer COVID-19 boosters for seniors, high-risk
More regulatory hurdles lie ahead before the dispensing of boosters can begin. The U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of the extra shots. A…
